Virginia Ruth Sanzone Sells 2,447 Shares of ICU Medical (NASDAQ:ICUI) Stock

by · The Cerbat Gem

ICU Medical, Inc. (NASDAQ:ICUI – Get Free Report) VP Virginia Ruth Sanzone sold 2,447 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the completion of the transaction, the vice president directly owned 19,460 shares in the company, valued at approximately $2,414,596.80. The trade was a 11.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

ICU Medical Stock Down 1.2%

ICUI stock traded down $1.54 during mid-day trading on Friday, hitting $121.45. The stock had a trading volume of 129,124 shares, compared to its average volume of 277,966. The company has a current ratio of 2.34, a quick ratio of 1.17 and a debt-to-equity ratio of 0.60. ICU Medical, Inc. has a 1-year low of $107.00 and a 1-year high of $160.29. The company has a fifty day moving average of $126.39 and a 200 day moving average of $138.44. The stock has a market capitalization of $3.04 billion, a price-to-earnings ratio of 65.42, a PEG ratio of 1.76 and a beta of 0.74.

ICU Medical (NASDAQ:ICUI – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating analysts’ consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million for the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The firm’s revenue for the quarter was down 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities analysts expect that ICU Medical, Inc. will post 6.31 EPS for the current fiscal year.

Institutional Trading of ICU Medical

A number of hedge funds have recently modified their holdings of the company. Lombard Odier Asset Management USA Corp bought a new stake in shares of ICU Medical in the 1st quarter worth approximately $323,000. Sei Investments Co. lifted its position in shares of ICU Medical by 40.8% in the 1st quarter. Sei Investments Co. now owns 48,632 shares of the medical instruments supplier’s stock worth $6,281,000 after acquiring an additional 14,093 shares during the period. Lido Advisors LLC lifted its position in shares of ICU Medical by 17.4% in the 1st quarter. Lido Advisors LLC now owns 2,910 shares of the medical instruments supplier’s stock worth $376,000 after acquiring an additional 431 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of ICU Medical by 2.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 4,519 shares of the medical instruments supplier’s stock worth $584,000 after acquiring an additional 125 shares during the period. Finally, Madison Asset Management LLC bought a new stake in shares of ICU Medical in the 1st quarter worth approximately $2,333,000. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on ICUI shares. KeyCorp lowered their price objective on ICU Medical from $180.00 to $164.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Piper Sandler lowered their price objective on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Weiss Ratings raised ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday. Finally, Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $169.00.

Read Our Latest Stock Analysis on ICUI

About ICU Medical

(Get Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Read More